Biogen Inc. (BIIB)

Biogen Inc., Consolidated Statement of Financial Position, Assets (quarterly data)

USD $ in thousands

Based on: 10-Q (filing date: 2018-10-23), 10-Q (filing date: 2018-07-24), 10-Q (filing date: 2018-04-24), 10-K (filing date: 2018-02-01), 10-Q (filing date: 2017-10-24), 10-Q (filing date: 2017-07-25), 10-Q (filing date: 2017-04-25), 10-K (filing date: 2017-02-02), 10-Q (filing date: 2016-10-26), 10-Q (filing date: 2016-07-21), 10-Q (filing date: 2016-04-21), 10-K (filing date: 2016-02-03), 10-Q (filing date: 2015-10-21), 10-Q (filing date: 2015-07-24), 10-Q (filing date: 2015-04-24), 10-K (filing date: 2015-02-04), 10-Q (filing date: 2014-10-22), 10-Q (filing date: 2014-07-23), 10-Q (filing date: 2014-04-23), 10-K (filing date: 2014-02-06), 10-Q (filing date: 2013-10-28), 10-Q (filing date: 2013-07-25), 10-Q (filing date: 2013-04-25).

---

Assets, Selected Items

Item	Description	The company
Current assets	Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.	Biogen Inc.'s current assets declined from 2018 to 2018 but then slightly increased from 2018 to 2018.
Property, plant and equipment, net	Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.	Biogen Inc.'s property, plant and equipment, net increased from 2018 to 2018 and from 2018 to 2018.
Non-current assets	Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold or consumed after one year or beyond the normal operating cycle, if longer.	Biogen Inc.'s non-current assets increased from 2018 to 2018 and from 2018 to 2018.
Total assets	Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.	Biogen Inc.'s total assets declined from 2018 to 2018 but then increased from 2018 to 2018 not reaching 2018 level.

---

Current Assets

Item	Description	The company
Cash and cash equivalents	Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.	Biogen Inc.'s cash and cash equivalents declined from 2018 to 2018 but then slightly increased from 2018 to 2018.
Marketable securities	Amount of investment in marketable security, classified as current.	Biogen Inc.'s marketable securities increased from 2018 to 2018 and from 2018 to 2018.
Accounts receivable, net	Amount due from customers or clients, within one year of the balance sheet date (or the normal operating cycle, whichever is longer), for goods or services (including trade receivables) that have been delivered or sold in the normal course of business, reduced to the estimated net realizable fair value by an allowance established by the entity of the amount it deems uncertain of collection.	Biogen Inc.'s accounts receivable, net increased from 2018 to 2018 and from 2018 to 2018.
Inventory	Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.	Biogen Inc.'s inventory increased from 2018 to 2018 but then slightly declined from 2018 to 2018.